- Takeda Pharmaceutical aims to go public in the next 5 to 10 years after Blackstone’s acquisition.
- The unit needs to expand its business overseas in Chinese-speaking markets.
- Takeda plans to sell its drug unit to Blackstone for $2.3 billion.
- The sale is expected to be completed by the end of March next year.
Japan’s Takeda Pharm....
Tags : JAPAN, JAPAN BUSINESS NEWS, BLACKSTONE ACQUISITION OF TAKEDA, PHARMACEUTICAL COMPANY, INVESTMENT FUND COMPANY,